ITUS said pre-market Friday that it has appointed Dr. Amit Kumar as its new chief executive officer.
Dr. Kumar succeeds Robert Berman, who has resigned. Dr. Kumar has served as the company’s executive chairman for the past year, and has been a director since joining the company in 2012.
Dr. Kumar is the inventor of the company’s Cchek cancer testing platform, and has been leading its development since inception. Dr. Kumar has over 25 years of experience working in cancer research and the biotech industry as a scientist, entrepreneur, CEO, board member and investor. Also on Friday, the company promoted CFO Mike Catelani to chief operating officer. Mike Catelani joined ITUS in November 2016 as CFO of the company, and is now taking on the additional title and responsibility of COO.